Legal Experts: Drug Industry May Use Licensing To Prevent Parallel Importation

In the wake of the U.S. Supreme Court's reversal of a lower court decision on patent exhaustion, which some see as partially clearing the way for drug importation, legal experts argue that the pharmaceutical industry will now turn to contract disputes over licensing to fight importation. The biotechnology lobby says the decision handed down late last month will create uncertainty for consumers and industry, and the brand lobby asserts the ruling could imperil pharmaceutical research and undermine U.S. innovation in...